Transforming Blood Cancer Detection Through European Innovation

The SANGUINE Project Showcase Event: Advancing the HemaChip from Research to Impact

Every year, around 300,000 people across the EU are diagnosed with a haematological malignancy, including leukaemia, lymphoma and multiple myeloma.

Yet diagnosing blood cancer remains a complex challenge. With more than 100 different types and subtypes, many diseases share overlapping clinical and laboratory features, requiring multiple tests to reach an accurate diagnosis.